Olanzapine-Samidorphan Boosts Treatment Adherence
New study shows improved patient persistence for schizophrenia and bipolar I disorder on combination therapy.
Updated on Oct. 27, 2026 in Substance Abuse
Live Poll
Do you believe consistent adherence to prescribed medication is the most important factor for managing chronic illness?
Researchers report that patients treated with olanzapine/samidorphan show higher treatment persistence compared to other antipsychotics. The analysis indicates significant reductions in hospitalizations and emergency department visits for those on the combination medication.
Why it matters
Maintaining adherence to antipsychotic medication is critical for preventing relapse and managing symptoms in patients with schizophrenia and bipolar I disorder. Higher persistence rates suggest a potentially more stable therapeutic outcome for these individuals.
The study measured a mean treatment persistence of 201.8 days for those on olanzapine/samidorphan. Combination users also saw an all-cause inpatient admission rate of 31.9%, compared to 46.0% for patients prescribed olanzapine alone.
The players
Academy of Managed Care Pharmacy
This is a professional organization dedicated to improving patient health through the specialty of managed care pharmacy.
The details
The research, which utilized data from the Komodo Healthcare Map database, matched Medicaid-insured adults 1:1 based on clinical and demographic variables. Investigators defined discontinuation as a minimum 45-day gap in therapy over the 12-month follow-up period.
Timeline
October 2020 to December 2024 served as the patient data collection period.
The findings were presented October 26-29, 2026, at the Academy of Managed Care Pharmacy Nexus 2026 meeting in San Diego.
The Big Picture
This study updates the performance benchmarks for second-generation antipsychotics, showing that combination therapy can extend patient adherence beyond the current industry standard.
Patients and healthcare providers may use these findings to discuss alternative medication options that could improve long-term adherence and reduce the likelihood of hospital visits. This analysis provides context for how therapy persistence directly influences the continuity of care for those with chronic mental health conditions.
The takeaway
Increased medication persistence is a primary goal for effective mental health management and overall patient safety. Patients should consult with their providers to determine if newer combination therapies are an appropriate fit for their specific treatment plans.
Further reading
For broader information regarding medication management and mental health, see the Substance Abuse section.
Source note: This article includes information reported by Ajmc.
Live Poll
Do you believe consistent adherence to prescribed medication is the most important factor for managing chronic illness?
